Parabilis Medicines
- Health & Biotech
- Cambridge, MA, US
- Founded 2016
- Public
- parabilismed.com
Clinical-stage biopharma, formerly FogPharma, developing cell-penetrant Helicon peptides against intracellular cancer targets such as the beta-catenin pathway.
$975MEquity raised in 2025–20262025 — · 2026 $975M · 2 equity rounds
$1.1BEquity raised, all time3 equity rounds sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 3 rounds · 7 sources · newest first
Earlier rounds not yet sourced. Parabilis Medicines was founded in 2016 and raised before 1 Mar 2024; only the rounds below are sourced so far, so its all-time equity total understates its history.
- IPO (Nasdaq: PBLS)Amount$670MPost-money—✓ Confirmed
- Series FAmount$305MPost-money—✓ Confirmed
- Series EAmount$145MPost-money—✓ Confirmed
- Earlier rounds not yet sourced
Investors 22
- Fidelity2
- RA Capital Management2
- Janus Henderson Investors1
- Nextech Invest1
- ARCH Venture Partners2
- Catalio Capital Management2
- Cormorant Asset Management2
- Foresite Capital2
- General Catalyst2
- GV2
- Marshall Wace2
- Samsara BioCapital2
- T. Rowe Price2
- venBio Partners2
- Farallon Capital Management
- Frazier Life Sciences
- Invus
- Milky Way Investments
- Rock Springs Capital
- Sixty Degree Capital
- Soleus Capital
- SymBiosis
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
TubulisHealth · $401M in 2025–2026Shared: Nextech Invest, Fidelity +2Encoded TherapeuticsHealth · $275M in 2025–2026Shared: ARCH Venture Partners, GV +3LifeMine TherapeuticsHealth · $263M in 2025–2026Shared: RA Capital Management, ARCH Venture Partners +2AnthropicAI Labs · $113B in 2025–2026Shared: General Catalyst, Fidelity +1RampFintech · $3.6B in 2025–2026Shared: General Catalyst, Fidelity +2KardiganHealth · $554M in 2025–2026Shared: ARCH Venture Partners, Fidelity +1
Also in the Cambridge hub see on the globe
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Parabilis Medicines and its logo are trademarks of their owners, used here for identification only.
